Skip to main content

Table 2 Type of infections, duration of treatment and clinical efficacy of tigecycline

From: Tigecycline use in serious nosocomial infections: a drug use evaluation

Type of infections n(%) Duration of treatment, days
Median (range)
Clinical efficacy
n(%)
Clinical failure
n (%)
Secondary peritonitis 46 (22) 9 (6- 18) 40 (88) 6 (12)
Tertiary peritonitis 41 (20) 15 ( 11-28) 32(78) 9 (22)
Other abdominal infections 12(6) 11 (7-17) 5 (42) 7 (58)
Pneumonia ( HAP, HCAP, VAP) 27 (13) 12 ( 8-21) 18 (67) 9 (33)
Pneumonia and bloodstream infections 29 (14) 17 (13-24) 19 (66) 10 (34)
Bloodstream infections 23 (11) 15 (12-18) 16 (70) 7 (30)
Complicated skin and soft tissue infections 17 (8) 11 (7-18) 13(76) 4 (24)
Empiric use in neutropenic 12 (6) 14 (9-17) 7 (58) 5(42)
Total 207 (100)   151 (73) 56 (27)
  1. HAP: hospital acquired pneumonia, HCAP: health care associated pneumonia, VAP: ventilator associated pneumonia